Den klinisk relevante toksicitet med hensyn til køn var den samme for den totale population af de patienter, som fik pemetrexed plus cisplatin.
Clinically relevant toxicities with respect to gender were similar to the overall population in patients receiving pemetrexed plus cisplatin.